Literature DB >> 29357998

[WebSurvCa: web-based estimation of death and survival probabilities in a cohort].

Ramon Clèries1, Alberto Ameijide2, Maria Buxó3, Mireia Vilardell4, José Miguel Martínez5, Francisco Alarcón6, David Cordero6, Ana Díez-Villanueva6, Yutaka Yasui7, Rafael Marcos-Gragera8, Maria Loreto Vilardell8, Marià Carulla2, Jaume Galceran2, Ángel Izquierdo9, Víctor Moreno10, Josep M Borràs11.   

Abstract

Relative survival has been used as a measure of the temporal evolution of the excess risk of death of a cohort of patients diagnosed with cancer, taking into account the mortality of a reference population. Once the excess risk of death has been estimated, three probabilities can be computed at time T: 1) the crude probability of death associated with the cause of initial diagnosis (disease under study), 2) the crude probability of death associated with other causes, and 3) the probability of absolute survival in the cohort at time T. This paper presents the WebSurvCa application (https://shiny.snpstats.net/WebSurvCa/), whereby hospital-based and population-based cancer registries and registries of other diseases can estimate such probabilities in their cohorts by selecting the mortality of the relevant region (reference population).
Copyright © 2017 SESPAS. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Breast cancer; Competing risk; Cáncer de mama; Exceso de mortalidad; Excess mortality; Net survival; Relative survival; Riesgos competitivos; Supervivencia neta; Supervivencia relativa

Mesh:

Year:  2018        PMID: 29357998     DOI: 10.1016/j.gaceta.2017.10.015

Source DB:  PubMed          Journal:  Gac Sanit        ISSN: 0213-9111            Impact factor:   2.139


  1 in total

1.  Incidence and Survival Trends of Pancreatic Cancer in Girona: Impact of the Change in Patient Care in the Last 25 Years.

Authors:  Adelaida García-Velasco; Lluís Zacarías-Pons; Helena Teixidor; Marc Valeros; Raquel Liñan; M Carmen Carmona-Garcia; Montse Puigdemont; Walter Carbajal; Raquel Guardeño; Núria Malats; Eric Duell; Rafael Marcos-Gragera
Journal:  Int J Environ Res Public Health       Date:  2020-12-19       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.